7 Matching Annotations
  1. May 2024
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
    1
    1. scibot 24 May 2024
      RRID:CVCL_1168

      DOI: 10.1158/2767-9764.CRC-24-0071

      Resource: (ATCC Cat# CRL-2289, RRID:CVCL_1168)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1168

      What is this?
      RRID:CVCL_1168
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11110724/
  3. Mar 2024
  4. www.sciencedirect.com www.sciencedirect.com
    Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling
    1
    1. scibot 29 Mar 2024
      Cat#CRL-2289

      DOI: 10.1016/j.chembiol.2024.02.013

      Resource: (ATCC Cat# CRL-2289, RRID:CVCL_1168)

      Curator: @abever99

      SciCrunch record: RRID:CVCL_1168

      What is this?
      RRID:CVCL_1168
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945624000874
  5. Apr 2023
  6. aacrjournals.org aacrjournals.org
    IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
    1
    1. scibot 19 Apr 2023
      CVCL_1168

      DOI: 10.1158/2767-9764.CRC-22-0477

      Resource: (ATCC Cat# CRL-2289, RRID:CVCL_1168)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1168

      What is this?
      RRID:CVCL_1168
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/3/4/576/725855/IOA-244-is-a-Non-ATP-competitive-Highly-Selective
  7. Jul 2021
  8. www.sciencedirect.com www.sciencedirect.com
    Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader
    1
    1. scibot 31 Jul 2021
      Human: DB (EZH2Y641N mutation)

      DOI: 10.1016/j.chembiol.2019.11.006

      Resource: (ATCC Cat# CRL-2289, RRID:CVCL_1168)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_1168

      What is this?
      RRID:CVCL_1168 RRIDCUR:Missing
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945619303642
  9. www.sciencedirect.com www.sciencedirect.com
    ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
    1
    1. scibot 22 Jul 2021
      RRID:CVCL_1168

      DOI: 10.1016/j.xcrm.2021.100350

      Resource: (ATCC Cat# CRL-2289, RRID:CVCL_1168)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_1168

      What is this?
      RRID:CVCL_1168
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379121001993
  10. May 2021
  11. www.sciencedirect.com www.sciencedirect.com
    Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas
    1
    1. scibot 07 May 2021
      CVCL_1168

      DOI: 10.1016/j.immuni.2020.11.002

      Resource: (ATCC Cat# CRL-2289, RRID:CVCL_1168)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1168

      What is this?
      RRID:CVCL_1168
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761320304672
  12. Nov 2018
  13. www.sciencedirect.com www.sciencedirect.com
    MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis
    1
    1. scibot 05 Nov 2018
      CVCL_1168

      Curator: @Jmenke

      Resource used:

      (DSMZ Cat# ACC-539, RRID:CVCL_1168)

      SciCrunch record: RRID:CVCL_1168

      Alternate resolvers: SciCrunch xml N2T identifiers.org

      What is this?

      RRID:CVCL_1168 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610818303660